Post doctoral fellow

One post-doctoral fellow position is available, starting from May 2024, in the Lab of Chemokine Biology leaded by prof Raffaella Bonecchi at the Department of Biomedicine of the Humanitas University. Humanitas University fosters a highly competitive, international, and scientifically enriching atmosphere, providing outstanding working conditions and access to state-of-the-art facilities and infrastructures, including Next Generation Sequencing, Cell Sorting and Imaging, and Animal Facilities.

About the project

The goal of this project is to elucidate the role of chemokine receptors in shaping the biology of innate immune cells to foster immune-based strategies in gastrointestinal and brain malignancies. Our approach integrates cutting-edge in vitro and in vivo models with state-ofthe-art technologies such as multicolor flow cytometry, imaging, and single-cell RNA sequencing.

Who we are looking for

We seek a candidate with a PhD in Biological Sciences, Biotechnology, or related disciplines, possessing expertise in immunology and prior experience with in vivo tumor models. Proficiency in English, strong independent work ethic, exceptional organizational skills, and a collaborative spirit are required.

What we offer

The successful candidate will receive a fixed-term contract

All candidate data collected from the application shall be processed in accordance with applicable law: Dlgs 198/2006 e dei Dlgs 215/2003 e 216/2003;  privacy ex artt. 13 e 14 del Reg. UE 2016/679.

To learn more:

- Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020 Sep;20(9):485-503.

- Bonecchi R, Mantovani A, Jaillon S Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy. Cancers (Basel). 2022 Jan 28;14(3):680.

- Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, Setten E, Recordati C, Crisafulli L, Ficara F, Mantovani A, Locati M, Bonecchi R ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and antimetastatic activity. Nat Commun. 2018 Feb 14;9(1):676.